Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News archive
News Archive Navigation
News Archive Navigation Language
November 2018
-
Artificial intelligence decodes cancer pathology images
Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.
-
Media ReleaseNew Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patientsEntresto® (sacubitril/valsartan) outperformed commonly used heart failure medicine enalapril in landmark study; delivered significantly greater and more rapid reductions in an established biomarker…
-
Women in Science: Wendy Winckler
Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.
-
Story From Our LabsWomen in Science: Jennifer Allport-Anderson
Cardiovascular researcher Jennifer Allport-Anderson describes the personal qualities and decisions that have made her a successful leader.
-
Story From Our LabsWomen in Science: Jean Silveri
Jean Silveri shares key insights from her legal career.
-
Story From Our LabsWomen in Science: Cyndy Grosskreutz
Physician-scientist Cyndy Grosskreutz explains why she transitioned from academia to industry.
-
Story From Our LabsWomen in Science: Alexandra Bach-Weidmuller
Alexandra Bach-Weidmuller, Head of Program and Project Management at NIBR, describes her path to leadership as lateral instead of upward.
-
Media ReleaseNovartis R&D update highlights industry leading development pipeline including potential blockbusters and advanced therapy platforms26 potential blockbusters in confirmatory development[1]. 13 projects in clinical development across Cell, Gene & Radioligand therapies. 60 major submissions[2] planned from 2019 to 2021…
-
Media ReleaseSandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and sustainability needsDecision follows FDA request for additional information to complement submission for biosimilar rituximab Sandoz stands behind safety, efficacy and quality of our biosimilar rituximab, which is…
-
Media ReleaseNovartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncologyAdditional analysis from pivotal Phase III SOLAR-1 clinical trial studying investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) and fulvestrant in patients with PIK3CA-mutated HR+/HER2-…
-
The realities of living with premenopausal metastatic breast cancer
Receiving a breast cancer diagnosis is difficult, but these young women faced an especially challenging diagnosis: stage IV metastatic breast cancer.
-
The importance of caregivers
Melanoma survivor T.J. Sharpe discusses his personal experience with cancer and the important role caregivers play in a patient’s road to recovery.
Pagination
- ‹ Previous page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- …
- 152
- › Next page